서울신약 / Seoul Shinyak Co., Ltd.
Seoul Shinyak Co., Ltd.'s KOBDi Score is 94.87 as of Sep 2026, up 6.12 points since Apr 2025; it rose in 7 and fell in 2 of the 12 monthly updates. As of Sep 2026 it is ahead of about 84% of companies in its industry, against 84% in Aug 2026 and 74% in Apr 2025. Its strongest position was 84% (Sep 2026) and its weakest 74% (Jul 2025).
A year earlier, in Aug 2025, its score was 88.65 and it was ahead of about 76% of companies in its industry.
| Sep 2026 | 94.87 | ahead of 84% |
| Aug 2026 | 94.82 | ahead of 84% |
| Jul 2026 | 94.14 | ahead of 84% |
| Jun 2026 | 93.42 | ahead of 84% |
| May 2026 | 93.42 | ahead of 84% |
| Apr 2026 | 93.42 | ahead of 84% |
| Mar 2026 | 92.65 | ahead of 84% |
| Feb 2026 | 93.33 | ahead of 84% |
| Dec 2025 | 93.17 | ahead of 84% |
| Aug 2025 | 88.65 | ahead of 76% |
| Jul 2025 | 87.83 | ahead of 74% |
| May 2025 | 88.75 | ahead of 74% |
| Apr 2025 | 88.75 | ahead of 74% |
| # | ||||
|---|---|---|---|---|
| (주)한국애보트진단 Abbott Diagnostics Korea Inc. | 500–999 | #72 | ||
| (주)재세 JAESAE CO.,LTD | 10–19 | #71 | ||
| 주식회사 이도팜 IDOPHARM | 10–19 | #74 | ||
| 보국(주) BO-KOOK | 1–4 | #75 | ||
| 고려양행 Korio Yang Haeng | 20–29 | #70 | ||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
|
Where is Seoul Shinyak Co., Ltd. located?
Seoul Shinyak Co., Ltd. is registered at Yongchon-gil, Maengdong-myeon, Eumseong-gun, Chungcheongbuk-do, South Korea (postal code 27734).
What industry is Seoul Shinyak Co., Ltd. in?
Seoul Shinyak Co., Ltd. belongs to Manufacturing › Pharmaceuticals & Biologics › Manufacturing of medical supplies and other medicine-related products.
How many employees does Seoul Shinyak Co., Ltd. have?
Seoul Shinyak Co., Ltd. has 10–19 employees.
What is Seoul Shinyak Co., Ltd.'s KOBDi Score?
94.87 as of September 2026, ahead of about 84% of companies in its industry.
Who are Seoul Shinyak Co., Ltd.'s competitors?
Similar companies include Abbott Diagnostics Korea, JAESAE and IDOPHARM.


